SI
What one share of Shoulder Innovations holds
Surgical and Medical Instruments and Apparatus
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.
Shoulder Innovations’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.17 |
|---|---|
| Profit | −$1.85 |
| Capex (buildings and equipment) | $0.53 |
| Free cash flow | −$2.48 |
| Cash and investments | $1.17 |
| Debt | $0.71 |
| Book value | $5.97 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2025 | $5.46 | −$4.65 | $0.85 | −$4.15 | — | $6.82 |